# A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)

> **NCT01235728** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 24 (actual)

## Conditions studied

- Psoriasis
- Plaque Psoriasis

## Interventions

- **DRUG:** MK-0873 2% Cream
- **DRUG:** MK-0873 vehicle (placebo) Cream
- **DRUG:** Calcitriol Cream

## Key facts

- **NCT ID:** NCT01235728
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-11-01
- **Primary completion:** 2011-04-01
- **Final completion:** 2011-04-01
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01235728

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01235728, "A Study to Evaluate and Compare the Efficacy and Pharmacokinetics of MK-0873 for the Treatment of Plaque Psoriasis (MK-0873-022)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01235728. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*